排序方式: 共有49条查询结果,搜索用时 31 毫秒
31.
门静脉高压症名称的由来至今巳有100多年的历史.它的治疗则经历了一个逐步发展和完善的过程.回顾这一历史,有利于进一步完善门静脉高压症的治疗. 相似文献
32.
XAGE-1是一种在多种肿瘤组织中表达的癌-睾丸抗原(cancer-testis antigen,CT抗原)[1],为了了解该抗原在结肠癌中的表达,我们采用巢式PCR方法检测了XAGE-1的4种不同剪接体基因在结肠癌组织中的表达情况,并分析XAGE-1b基因表达与结肠癌患者临床特点的关系,为结肠癌的肿瘤免疫治疗提供理论依据。 相似文献
33.
Objective To investigate the diagnosis and treatment of rectal carcinoid. Methods Clinical data of 16 patients of rectal carcinoids in our hospital from January 2000 to December 2009 were analyzed retrospectively. Related literatures were reviewed. Results Among the patients included, 11 cases(68.8%)suffered from hypogastralgia, 3 cases(18.8%)bloody stool, 3 cases(18.8%)defecation number increase. All the patients underwent enteroscopy. The average size in diameter of all the tumors was 8.8 mm. 81.3% of the tumors ≤10 mm in diameter. The average distance from tumor to anus was 6.8 cm and 87.5% of the tumors ≤8 cm in distance, Only 25% of all the cases were diagnosed preoperatively, most cases were diagnosed as other diseases and definitely diagnosed by postoperative pathology. 14 cases underwent operation as radical resection of rectal carcinoma, and 2 cases endoscopic removal. There was no operative death and postoperative five-year survival rate is 69.2%. Conclusions Preoperative diagnosis rectal carcinoid is difficult.Misdiagnosis rate is high. The key point of improving diagnosis of this disease is annal digital examination. Enteroscopy and pathology, operation is the first choice to treat rectal carcinoid. 相似文献
34.
门静脉高压症名称的由来至今巳有100多年的历史.它的治疗则经历了一个逐步发展和完善的过程.回顾这一历史,有利于进一步完善门静脉高压症的治疗. 相似文献
35.
目的讨论临床路径在结节性甲状腺肿手术中的应用及效果。方法以2009年1月—2011年6月湖北医药学院附属人民医院院结节性甲状腺肿手术非临床路径实施患者(60例)为对照组,以2011年7月—2012年5月该院结节性甲状腺肿实施临床路径手术患者(60例)为路径组,回顾分析2组患者的住院费用、住院时间、并发症、意外事件、医患争执、患者满意率及健康知识知晓率评分情况。结果路径组与对照组比较,各项观察指标差异均有统计学意义(P0.05)。结论实施结节性甲状腺肿临床路径后可明显提高医疗质量,体现"人本主义"伦理原则,值得在临床工作中推广应用。 相似文献
36.
37.
门静脉高压症名称的由来至今巳有100多年的历史.它的治疗则经历了一个逐步发展和完善的过程.回顾这一历史,有利于进一步完善门静脉高压症的治疗. 相似文献
38.
39.
门静脉高压性脾肿大、脾功能亢进(简称脾亢)的患者由于脾脏病理性功能增强,导致了循环血液中的血细胞呈现不同程度的减少,但血细胞减少的程度、范围是否有一个量化的指标?近15年来,笔者经治门静脉高压性脾肿大脾亢患者278例,占同期收治门静脉高压性脾肿大病例的90%,报告如下。[第一段] 相似文献
40.